dangers of glp 1 A monthly GLP-1 dose could cut the number shots patients take each year from 52 to 12. Side effects from the drug — mainly gastrointestinal symptoms — were similar to or Lawsuit highlights the dangers of

In beta-cells, GIP stimulates insulin secretion in a glucose-dependent manner 56 , and in alpha-cells, GIP stimulates glucagon in an amino-acid and glucose-dependent manner 57

Once the decision to switch is made, an individualised approach is recommended, based on considerations that include reimbursement requirements, treatment duration with (and dose of) previous GLP1RA, the patient's experience initiating the prior GLP1RA, any concomitant treatment and clinical characteristics

4 Pricing and affordability are not side details GLP-1 analytics is inseparable from affordability

Notable industry conferences such as the American Diabetes Association (ADA) Scientific Sessions and European Association for the Study of Diabetes (EASD) Annual Meeting have provided significant platforms for knowledge exchange, innovation showcases, and discussions on regulatory advancements

Second, consider how alcohol interacts with diabetes management

doi: 10.1038/s42255-024-01041-8 69 ZhangHHeZChenYChaoJChengXMaoJet al